Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Aripiprazole
Otsuka Pharmaceuticals (U.K.
N05AX12
Aripiprazole
400mg
Powder and solvent for suspension for injection
Intramuscular
No Controlled Drug Status
Valid as a prescribable product
BNF: ; GTIN: 5038256000463
_PACKAGE LEAFLET: INFORMATION FOR THE USER_ ABILIFY MAINTENA _300 MG POWDER AND SOLVENT FOR PROLONGED-RELEASE SUSPENSION FOR INJECTION IN _ _PRE-FILLED SYRINGE_ ABILIFY MAINTENA _400 MG POWDER AND SOLVENT FOR PROLONGED-RELEASE SUSPENSION FOR INJECTION IN _ _PRE-FILLED SYRINGE_ _aripiprazole_ _READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU RECEIVE THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT _ _INFORMATION FOR YOU._ _- _ _Keep this leaflet. You may need to read it again._ _- _ _If you have any further questions, ask your doctor or nurse._ _- _ _If you get any side effects, talk to your doctor or nurse. This includes any possible side effects _ _not listed in this leaflet. See section 4._ _WHAT IS IN THIS LEAFLET_ _1. _ _What _ Abilify Maintena _is and what it is used for_ _2. _ _What you need to know before you are given _ Abilify Maintena _3. _ _How _ Abilify Maintena _is given_ _4. _ _Possible side effects_ _5. _ _How to store _ Abilify Maintena _6. _ _Contents of the pack and other information_ _1. _ _WHAT _ABILIFY MAINTENA _IS AND WHAT IT IS USED FOR_ Abilify Maintena _contains the active substance aripiprazole and belongs to a group of medicines _ _called antipsychotics. It is used to treat schizophrenia - a disease with symptoms such as hearing, _ _seeing or sensing things which are not there, suspiciousness, mistaken beliefs, incoherent speech and _ _behaviour and emotional flatness. People with this condition may also feel depressed, guilty, anxious _ _or tense._ Abilify Maintena _is intended for adult patients with schizophrenia who are sufficiently stabilised _ _during treatment with oral aripiprazole._ _2. _ _WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN _ABILIFY MAINTENA _DO NOT USE _ABILIFY MAINTENA_:_ _- _ _if you are allergic to aripiprazole or any of the other ingredients of this medicine (listed in _ _section 6)._ _WARNINGS AND PRECAUTIONS_ _Talk to your doctor or nurse before you are given _ Abilify Maintena _._ _Suicidal thoughts and behaviours have been reported during aripiprazole treatment. Tell y Read the complete document
OBJECT 1 ABILIFY MAINTENA 400 MG POWDER AND SOLVENT FOR PROLONGED-RELEASE SUSPENSION FOR INJECTION IN PRE- FILLED SYRINGE Summary of Product Characteristics Updated 05-Feb-2018 | Otsuka Pharmaceuticals (UK) Ltd 1. Name of the medicinal product Abilify Maintena 300 mg powder and solvent for prolonged-release suspension for injection Abilify Maintena 400 mg powder and solvent for prolonged-release suspension for injection Abilify Maintena 300 mg powder and solvent for prolonged-release suspension for injection in pre-filled syringe Abilify Maintena 400 mg powder and solvent for prolonged-release suspension for injection in pre-filled syringe 2. Qualitative and quantitative composition Abilify Maintena 300 mg powder and solvent for prolonged-release suspension for injection Each vial contains 300 mg aripiprazole. Abilify Maintena 400 mg powder and solvent for prolonged-release suspension for injection Each vial contains 400 mg aripiprazole. Abilify Maintena 300 mg powder and solvent for prolonged-release suspension for injection in pre-filled syringe Each pre-filled syringe contains 300 mg aripiprazole. Abilify Maintena 400 mg powder and solvent for prolonged-release suspension for injection in pre-filled syringe Each pre-filled syringe contains 400 mg aripiprazole. After reconstitution each ml of suspension contains 200 mg aripiprazole. For the full list of excipients, see section 6.1. 3. Pharmaceutical form Abilify Maintena 300 mg powder and solvent for prolonged-release suspension for injection Abilify Maintena 400 mg powder and solvent for prolonged-release suspension for injection Powder and solvent for prolonged-release suspension for injection Abilify Maintena 300 mg powder and solvent for prolonged-release suspension for injection in pre-filled syringe Abilify Maintena 400 mg powder and solvent for prolonged-release suspension for injection in pre-filled syringe Powder and solvent for prolonged-release suspension for injection in pre-filled syringe Powder: white to off-white Solvent: clear solution 4. Clinic Read the complete document